Advent, Bain gain edge in bid for Pfizer's Brazil venture -sources

SAO PAULO, Oct 21 (Reuters) - Bain Capital LP, Advent International Corp and Torrent Capital Investment Corp are on a shortlist of suitors for a Brazilian generic drug making joint-venture in which Pfizer Inc has a 40 percent stake, two people with direct knowledge of the situation said on Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.